Skip to main content
. 2012 Jan 6;14(4):445–450. doi: 10.1093/icvts/ivr142

Figure 2:

Figure 2:

(A) Time-related prevalence of class I/III anti-arrhythmic use after a hybrid monolateral approach with a monopolar device. (B) Time-related prevalence of class I/III anti-arrhythmic use after a hybrid bilateral approach with bipolar device. (C) Time-related prevalence of Warfarin use after a hybrid monolateral approach with a monopolar device. (D) Time-related prevalence of Warfarin use after a hybrid bilateral approach with bipolar device.